Fig. 3.

Estimates of vaccine efficacy in Veterans without/with a diagnosis of cancer as regards infection (3A) and death within 60 days of infection (3B). The data is plotted for all Veterans without/with a cancer diagnosis and with a cancer diagnosis by hematologic or solid tumor malignancy and across individual malignancies. Compared to Veterans without a diagnosis of cancer, vaccine efficacy amongst Veterans with a diagnosis of cancer is comparable in preventing infection and death within 60 days of infection, except for preventing death in Veterans with diagnoses of leukemia. Asterisks coincide with P-value of difference between the cohort of vaccinated compared the corresponding unvaccinated in each group.